# EDGAR Filing Document

**Accession Number:** 0001845809
**File Stem:** 0000940400-25-014942
**Filing Date:** 2025-12
**Character Count:** 14131
**Document Hash:** 99033ac6095c392b9cd6679d12725d2e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000940400-25-014942.hdr.sgml**: 20251229

**ACCESSION NUMBER**: 0000940400-25-014942

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251031

**FILED AS OF DATE**: 20251229

**DATE AS OF CHANGE**: 20251229

**PERIOD START**: 20260430

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Putnam ETF Trust
- **CENTRAL INDEX KEY:** 0001845809

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-23643
- **FILM NUMBER:** 251606215

**BUSINESS ADDRESS:**
- **STREET 1:** 100 FEDERAL STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02111
- **BUSINESS PHONE:** 6177601060

**MAIL ADDRESS:**
- **STREET 1:** 100 FEDERAL STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02111

## Series and Classes Contracts Data

### Putnam BioRevolution ETF (Series ID: S000077138)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000237308 | -            |  |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Putnam ETF Trust

- **b. Investment Company Act file number:** 811-23643

- **c. CIK number of Registrant:** 0001845809

- **d. LEI of Registrant:** 549300EMFKH8ETCKNO35

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** One Franklin Parkway

  - **City:** San Mateo

  - **State:** CA

  - **Foreign country:** US

  - **Zip / Postal Code:** 94403-1906

  - **Telephone number:** 650-312-2000

**Item A.2. Information about the Series.**

- **a. Name of Series:** Putnam BioRevolution ETF

- **b. EDGAR series identifier (if any):** S000077138

- **c. LEI of Series:** 5493008EYTUACODOQI60

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-04-30

- **b. Date as of which information is reported:** 2025-10-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **Yes**

### Fund Information

**Total Assets:** $4667788.16

**Total Liabilities:** $3172.48

**Net Assets:** $4664615.68

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000237308 | 5.03%                | -1.45%               | 3.70%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $-13384.35               | $266609.91                                 |
| Month 2  | $0.00                    | $-76524.79                                 |
| Month 3  | $148868.03               | $59171.29                                  |

### Schedule of Portfolio Investments

| Name                                | Title                               | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Bio-Rad Laboratories Inc            | Bio-Rad Laboratories Inc            | CUSIP: 090572207<br>LEI: 549300ZC1GPV35XYDK53 | Long             | EC               | CORP              | US        |       697 | NS      | $222726.35    | 4.77%             |  |  |  | No            |                  1 | On Loan: No      |
| Symrise AG                          | Symrise AG                          | CUSIP: 000000000<br>LEI: 529900D82I6R9601CF26 | Long             | EC               | CORP              | DE        |       887 | NS      | $73387.92     | 1.57%             |  |  |  | No            |                  1 | On Loan: No      |
| Regeneron Pharmaceuticals Inc       | Regeneron Pharmaceuticals Inc       | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |       245 | NS      | $159691.00    | 3.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Absci Corp                          | Absci Corp                          | CUSIP: 00091E109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      6392 | NS      | $27357.76     | 0.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Ascendis Pharma A/S                 | Ascendis Pharma A/S                 | CUSIP: 04351P101<br>LEI: 549300B66JN3W3J8GH73 | Long             | EC               | CORP              | DK        |      1086 | NS      | $218937.60    | 4.69%             |  |  |  | No            |                  1 | On Loan: No      |
| AstraZeneca PLC                     | AstraZeneca PLC                     | CUSIP: 046353108<br>LEI: PY6ZZQWO2IZFZC3IOL08 | Long             | EC               | CORP              | GB        |      2523 | NS      | $207895.20    | 4.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Argenx SE                           | Argenx SE                           | CUSIP: 04016X101<br>LEI: 7245009C5FZE6G9ODQ71 | Long             | EC               | CORP              | NL        |       119 | NS      | $97401.50     | 2.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Putnam Government Money Market Fund | Putnam Government Money Market Fund | CUSIP: 74680A869<br>LEI: 549300SEUI2XMME8T893 | Long             | STIV             | RF                | US        |    222257 | NS      | $222256.92    | 4.76%             |  |  |  | No            |                  1 | On Loan: No      |
| Avantor Inc                         | Avantor Inc                         | CUSIP: 05352A100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      7431 | NS      | $87834.42     | 1.88%             |  |  |  | No            |                  1 | On Loan: No      |
| Thermo Fisher Scientific Inc        | Thermo Fisher Scientific Inc        | CUSIP: 883556102<br>LEI: HCHV7422L5HDJZCRFL38 | Long             | EC               | CORP              | US        |       755 | NS      | $428379.45    | 9.18%             |  |  |  | No            |                  1 | On Loan: No      |
| Alnylam Pharmaceuticals Inc         | Alnylam Pharmaceuticals Inc         | CUSIP: 02043Q107<br>LEI: 529900S3ZI14OWRJII50 | Long             | EC               | CORP              | US        |       129 | NS      | $58829.16     | 1.26%             |  |  |  | No            |                  1 | On Loan: No      |
| Darling Ingredients Inc             | Darling Ingredients Inc             | CUSIP: 237266101<br>LEI: L1N0SPPKS7EXZYUMZ898 | Long             | EC               | CORP              | US        |      3696 | NS      | $118456.80    | 2.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Zoetis Inc                          | Zoetis Inc                          | CUSIP: 98978V103<br>LEI: 549300HD9Q1LOC9KLJ48 | Long             | EC               | CORP              | US        |       984 | NS      | $141784.56    | 3.04%             |  |  |  | No            |                  1 | On Loan: No      |
| On Holding AG                       | On Holding AG                       | CUSIP: 000000000<br>LEI: 506700FB3467B9W95526 | Long             | EC               | CORP              | CH        |      1781 | NS      | $66164.15     | 1.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Novonesis Novozymes B               | Novonesis Novozymes B               | CUSIP: 670108109<br>LEI: 529900T6WNZXD2R3JW38 | Long             | EC               | CORP              | DK        |      3549 | NS      | $211804.32    | 4.54%             |  |  |  | No            |                  1 | On Loan: No      |
| NVIDIA Corp                         | NVIDIA Corp                         | CUSIP: 67066G104<br>LEI: 549300S4KLFTLO7GSQ80 | Long             | EC               | CORP              | US        |      1184 | NS      | $239748.16    | 5.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Borregaard ASA                      | Borregaard ASA                      | CUSIP: 000000000<br>LEI: 5967007LIEEXZXGYXC05 | Long             | EC               | CORP              | NO        |      4569 | NS      | $86605.42     | 1.86%             |  |  |  | No            |                  1 | On Loan: No      |
| Corteva Inc                         | Corteva Inc                         | CUSIP: 22052L104<br>LEI: 549300WZN9I2QKLS0O94 | Long             | EC               | CORP              | US        |      3713 | NS      | $228126.72    | 4.89%             |  |  |  | No            |                  1 | On Loan: No      |
| Biogen Inc                          | Biogen Inc                          | CUSIP: 09062X103<br>LEI: W8J5WZB5IY3K0NDQT671 | Long             | EC               | CORP              | US        |       695 | NS      | $107217.65    | 2.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Ingevity Corp                       | Ingevity Corp                       | CUSIP: 45688C107<br>LEI: 5493009UTFC4B5IMGF87 | Long             | EC               | CORP              | US        |      2347 | NS      | $126080.84    | 2.70%             |  |  |  | No            |                  1 | On Loan: No      |
| PPG Industries Inc                  | PPG Industries Inc                  | CUSIP: 693506107<br>LEI: 549300BKPEP01R3V6C59 | Long             | EC               | CORP              | US        |       617 | NS      | $60311.75     | 1.29%             |  |  |  | No            |                  1 | On Loan: No      |
| AbbVie Inc                          | AbbVie Inc                          | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |      1149 | NS      | $250527.96    | 5.37%             |  |  |  | No            |                  1 | On Loan: No      |
| Bio-Techne Corp                     | Bio-Techne Corp                     | CUSIP: 09073M104<br>LEI: 54930073RLKQ51TILZ35 | Long             | EC               | CORP              | US        |      2059 | NS      | $128831.63    | 2.76%             |  |  |  | No            |                  1 | On Loan: No      |
| DuPont de Nemours Inc               | DuPont de Nemours Inc               | CUSIP: 26614N102<br>LEI: 5493004JF0SDFLM8GD76 | Long             | EC               | CORP              | US        |      2042 | NS      | $166729.30    | 3.57%             |  |  |  | No            |                  1 | On Loan: No      |
| Bunge Global SA                     | Bunge Global SA                     | CUSIP: 000000000<br>LEI: 254900IVXSV9K0B7PO26 | Long             | EC               | CORP              | US        |       556 | NS      | $52597.60     | 1.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Cadence Design Systems Inc          | Cadence Design Systems Inc          | CUSIP: 127387108<br>LEI: GCT7RXJOGLXPV0NXZY22 | Long             | EC               | CORP              | US        |       520 | NS      | $176118.80    | 3.78%             |  |  |  | No            |                  1 | On Loan: No      |
| ICON PLC                            | ICON PLC                            | CUSIP: 000000000<br>LEI: 6354008SRQGEMC4XFI67 | Long             | EC               | CORP              | IE        |       900 | NS      | $154638.00    | 3.32%             |  |  |  | No            |                  1 | On Loan: No      |
| CRISPR Therapeutics AG              | CRISPR Therapeutics AG              | CUSIP: 000000000<br>LEI: 506700O6IRRIQLT3W370 | Long             | EC               | CORP              | CH        |       401 | NS      | $25659.99     | 0.55%             |  |  |  | No            |                  1 | On Loan: No      |
| Danaher Corp                        | Danaher Corp                        | CUSIP: 235851102<br>LEI: S4BKK9OTCEWQ3YHPFM11 | Long             | EC               | CORP              | US        |       691 | NS      | $148827.58    | 3.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co                      | Eli Lilly & Co                      | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |       213 | NS      | $183789.18    | 3.94%             |  |  |  | No            |                  1 | On Loan: No      |
| Vertex Pharmaceuticals Inc          | Vertex Pharmaceuticals Inc          | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |       143 | NS      | $60856.51     | 1.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Danone SA                           | Danone SA                           | CUSIP: 000000000<br>LEI: 969500KMUQ2B6CBAF162 | Long             | EC               | CORP              | FR        |       995 | NS      | $87943.28     | 1.89%             |  |  |  | No            |                  1 | On Loan: No      |
| Sanofi SA                           | Sanofi SA                           | CUSIP: 000000000<br>LEI: 549300E9PC51EN656011 | Long             | EC               | CORP              | FR        |       361 | NS      | $36450.94     | 0.78%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2025-12-26

**Name of Applicant:** Putnam ETF Trust

**Signature:** Monica Krogh

**Name of Signer:** Monica Krogh

**Title:** Assistant Treasurer Controller, US Fund Administration and Oversight